Who Buys Moxifloxacin from India — 731 Importers Behind a $32.8M Market
India's moxifloxacin import market is served by 731 active buyers who collectively imported $32.8M across 2,413 shipments. NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) leads with a 42.2% market share, followed by AUROLOGISTICS LLC, (AUROBINDO PHARM and MYLAN INSTITUTIONAL INC 2898. The top 5 buyers together control 49.9% of total import value, reflecting a moderately competitive buyer landscape.
Top Moxifloxacin Importers — Ranked by Import Value
NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) is the leading moxifloxacin importer from India, holding a 42.2% share of the $32.8M market across 2,413 shipments from 731 buyers. The top 5 buyers — NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA), AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES), I+ SOLUTIONS, (NETHERLANDS) — collectively control 49.9% of total import value.
Top Moxifloxacin Buyers & Importers
Ranked by import value · 731 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | NATIONAL TUBERCULOSIS AND LEPROSYNIGERIA MOXIFLOXACIN HYDROCHLORIDE 400 MG TABLETS.MOXIFLOXACIN HYDROCHLORIDE 400MG TABLETS.MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/V | $13.8M | 5 | 42.2% |
| 2 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $744.3K | 5 | 2.3% |
| 3 | MYLAN INSTITUTIONAL INC 2898UNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $742.1K | 5 | 2.3% |
| 4 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $569.4K | 5 | 1.7% |
| 5 | I+ SOLUTIONS,NETHERLANDS FLOXSAFE 400MGFCA +PFRC 10X10SFLOXSAFE 400MGFCA +PFRC 10X10SNOSFLOXSAFE 400MGMOXIFLOXACIN 400MGFCA +PFRC 10X10S | $485.2K | 5 | 1.5% |
| 6 | AUROBINDO PHARMA USA., INC,UNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $442.3K | 5 | 1.3% |
| 7 | TOPONE DISTRIBUTION LTDCAMBODIA MFLOX [MOXIFLOXACIN 0.5% W/V - 5ML]MSN LABS, FLOXSAFE 400 (MOXIFLOXACIN 400AUROMOX[MOXIFLOXACIN 0.5% W/V-1ML] | $389.9K | 5 | 1.2% |
| 8 | MICRO NOVA PHARMACEUTICALS INDNIGERIA MOXIFLOXACIN HYDROCHLORIDE 400 MG TABLETS.MOXIFLOXACIN HYDROCHLORIDE 400MG TABLETS.MICROMOX 400 (MOXIFLOXACIN 400MG TABLETS | $383.9K | 5 | 1.2% |
| 9 | I+SOLUTIONSNETHERLANDS FLOXSAFE 400MGFCA +PFRC 10X10SFLOXSAFE 400MGFCA +PFRC 10X10SNOSFLOXSAFE 400MGMOXIFLOXACIN 400MGFCA +PFRC 10X10S | $383.6K | 5 | 1.2% |
| 10 | J. KNIPPER & COMPANYUNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $381.1K | 5 | 1.2% |
| 11 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $372.3K | 5 | 1.1% |
| 12 | MAXIM INTER-CORPORATION LTDTHAILAND MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTIMOXI MAC - TAX INVOICE NO:714201272 DT: 20.03.2025MOXI-MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI | $366.4K | 5 | 1.1% |
| 13 | PLANET PHARMA SAFRANCE MOXIFLOXACIN TAB 400MG 7BL FR VIA | $341.8K | 5 | 1.0% |
| 14 | HAWKARY PHARMACEUITCAL CO.*IRAQ APDROPS EYE DROPS[MOXIFLOXACIN HYDROCHLO | $335.4K | 5 | 1.0% |
| 15 | XXROBXXDO XXARMXXUSAXXNCUNITED STATES MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% W/VMOXIFLOXACIN HYDROCHLORIDE TABLETS 400MGMOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $331.7K | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Moxifloxacin — and from which countries?
Flow of Moxifloxacin exports from India: each country's share and the named importers behind the numbers
Moxifloxacin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Nigeria
Nigeria emerges as the first largest importing country, achieving a total trade value of $14.7M through 8 shipments. This represents a market share of 44.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• NATIONAL TUBERCULOSIS AND LEPROSY - $13.8M (94.2% of country's total business)
• MICRO NOVA PHARMACEUTICALS IND - $383.9K (2.6% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $1.8M, indicating premium pricing strategy compared to the market average of $13.6K.
Nigeria is a key market for Moxifloxacin imports, representing 44.8% of total trade value.
2United States
United States emerges as the second largest importing country, achieving a total trade value of $5.8M through 82 shipments. This represents a market share of 17.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• AUROLOGISTICS LLC, (AUROBINDO PHARM - $744.3K (12.9% of country's total business)
• MYLAN INSTITUTIONAL INC 2898 - $742.1K (12.9% of country's total business)
• NORTHSTAR DISTRIBUTION CENTER 8912 - $569.4K (9.9% of country's total business)
• AUROBINDO PHARMA USA., INC, - $442.3K (7.7% of country's total business)
• J. KNIPPER & COMPANY - $381.1K (6.6% of country's total business)
• Rest of United States's importers - $2.9M (50.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $70.2K, indicating premium pricing strategy compared to the market average of $13.6K.
United States is a key market for Moxifloxacin imports, representing 17.5% of total trade value.
3Netherlands
Netherlands emerges as the third largest importing country, achieving a total trade value of $1.7M through 16 shipments. This represents a market share of 5.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• I+ SOLUTIONS, - $485.2K (28.9% of country's total business)
• I+SOLUTIONS - $383.6K (22.9% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $104.9K, indicating premium pricing strategy compared to the market average of $13.6K.
Netherlands is a key market for Moxifloxacin imports, representing 5.1% of total trade value.
4Thailand
Thailand emerges as the fourth largest importing country, achieving a total trade value of $1.0M through 12 shipments. This represents a market share of 3.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• MAXIM INTER-CORPORATION LTD - $366.4K (35.4% of country's total business)
• MAXIM INTER-CORPORATION LTD. - $295.5K (28.5% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $86.3K, indicating premium pricing strategy compared to the market average of $13.6K.
Thailand is a key market for Moxifloxacin imports, representing 3.2% of total trade value.
5France
France emerges as the fifth largest importing country, achieving a total trade value of $737.5K through 12 shipments. This represents a market share of 2.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• PLANET PHARMA SA - $341.8K (46.3% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $61.5K, indicating premium pricing strategy compared to the market average of $13.6K.
France is a key market for Moxifloxacin imports, representing 2.2% of total trade value.
Buyer Segment Analysis
TransData Nexus Moxifloxacin buyer market intelligence
1Buyer Segment Analysis
The importers of Moxifloxacin from India can be categorized into several key segments:
1. Government Procurement Agencies: These entities are responsible for national health initiatives and bulk purchasing for public health programs. The largest buyer in this category is the National Tuberculosis and Leprosy Control Programme in Nigeria, accounting for $13.84 million in imports. Their purchasing behavior typically involves large-volume orders aligned with government tenders and health campaigns.
2. Pharmaceutical Distributors: Companies that import and distribute pharmaceuticals to various healthcare providers. Examples include Aurobindo Pharma USA, Inc. ($0.44 million) and Northstar Distribution Center ($0.57 million) in the United States. These distributors often place consistent orders to maintain supply chains for hospitals and pharmacies.
3. Contract Manufacturers: Organizations that import active pharmaceutical ingredients (APIs) or finished products for further processing or packaging. Mylan Institutional Inc. ($0.74 million) in the United States falls into this category. Their purchasing patterns are driven by production schedules and client demands.
4. International Health Organizations: Entities like I+ Solutions in the Netherlands ($0.49 million) procure pharmaceuticals for global health programs. Their orders are often large and periodic, corresponding with specific health initiatives.
5. Retail Chains and Hospital Groups: While not prominently featured among the top buyers, these entities import Moxifloxacin to meet the needs of their patient populations, with purchasing behaviors influenced by local demand and treatment protocols.
Country-Specific Import Regulations
TransData Nexus Moxifloxacin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Moxifloxacin are as follows:
1. Nigeria:
2. United States:
3. Netherlands:
4. Thailand:
5. France:
Demand Drivers & Market Opportunity
TransData Nexus Moxifloxacin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Moxifloxacin in importing countries is driven by several factors:
1. Disease Prevalence: Moxifloxacin is commonly used to treat respiratory tract infections, including tuberculosis (TB). Countries like Nigeria have high TB prevalence, necessitating substantial procurement of effective antibiotics.
2. Government Healthcare Programs: National health initiatives, such as Nigeria's National Tuberculosis and Leprosy Control Programme, drive significant demand for Moxifloxacin to combat TB.
3. Universal Health Coverage Expansion: Efforts to expand healthcare access in countries like Thailand and France increase the demand for essential medicines, including Moxifloxacin.
4. WHO Essential Medicines List Procurement: Moxifloxacin is listed on the WHO Essential Medicines List, prompting countries to include it in their procurement for public health programs.
5. Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, leading to bulk purchases of Moxifloxacin to meet public health needs.
With 731 buyers across 137 countries, the global demand for Moxifloxacin reflects its critical role in treating bacterial infections and underscores the importance of understanding the diverse buyer landscape and regulatory environments.
Common Questions — Moxifloxacin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest moxifloxacin buyer importing from India?
Based on import volume and value, NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) leads with $13.8M in imports and a 42.2% market share — the highest of any single moxifloxacin importer. AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) are the next largest buyers.
QHow many companies buy moxifloxacin from India?
There are 731 active moxifloxacin buyers importing from India, with a combined market of $32.8M across 2,413 shipments to 137 countries. The top 5 buyers hold 49.9% of total import value, while the remaining 726 buyers handle the other 50.1%.
QWhich countries import the most moxifloxacin from India?
The top importing countries for moxifloxacin from India are Nigeria (44.8%), United States (17.5%), Netherlands (5.1%), Thailand (3.2%), France (2.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of moxifloxacin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for moxifloxacin from India?
The average import transaction value for moxifloxacin from India is $13.6K, with an average unit price of $7.12 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Moxifloxacin buyer market intelligence
1Buyer Segment Analysis
The importers of Moxifloxacin from India can be categorized into several key segments:
1. Government Procurement Agencies: These entities are responsible for national health initiatives and bulk purchasing for public health programs. The largest buyer in this category is the National Tuberculosis and Leprosy Control Programme in Nigeria, accounting for $13.84 million in imports. Their purchasing behavior typically involves large-volume orders aligned with government tenders and health campaigns.
2. Pharmaceutical Distributors: Companies that import and distribute pharmaceuticals to various healthcare providers. Examples include Aurobindo Pharma USA, Inc. ($0.44 million) and Northstar Distribution Center ($0.57 million) in the United States. These distributors often place consistent orders to maintain supply chains for hospitals and pharmacies.
3. Contract Manufacturers: Organizations that import active pharmaceutical ingredients (APIs) or finished products for further processing or packaging. Mylan Institutional Inc. ($0.74 million) in the United States falls into this category. Their purchasing patterns are driven by production schedules and client demands.
4. International Health Organizations: Entities like I+ Solutions in the Netherlands ($0.49 million) procure pharmaceuticals for global health programs. Their orders are often large and periodic, corresponding with specific health initiatives.
5. Retail Chains and Hospital Groups: While not prominently featured among the top buyers, these entities import Moxifloxacin to meet the needs of their patient populations, with purchasing behaviors influenced by local demand and treatment protocols.
Country-Specific Import Regulations
TransData Nexus Moxifloxacin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Moxifloxacin are as follows:
1. Nigeria:
2. United States:
3. Netherlands:
4. Thailand:
5. France:
Demand Drivers & Market Opportunity
TransData Nexus Moxifloxacin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Moxifloxacin in importing countries is driven by several factors:
1. Disease Prevalence: Moxifloxacin is commonly used to treat respiratory tract infections, including tuberculosis (TB). Countries like Nigeria have high TB prevalence, necessitating substantial procurement of effective antibiotics.
2. Government Healthcare Programs: National health initiatives, such as Nigeria's National Tuberculosis and Leprosy Control Programme, drive significant demand for Moxifloxacin to combat TB.
3. Universal Health Coverage Expansion: Efforts to expand healthcare access in countries like Thailand and France increase the demand for essential medicines, including Moxifloxacin.
4. WHO Essential Medicines List Procurement: Moxifloxacin is listed on the WHO Essential Medicines List, prompting countries to include it in their procurement for public health programs.
5. Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, leading to bulk purchases of Moxifloxacin to meet public health needs.
With 731 buyers across 137 countries, the global demand for Moxifloxacin reflects its critical role in treating bacterial infections and underscores the importance of understanding the diverse buyer landscape and regulatory environments.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 731 global importers of Moxifloxacin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,413 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 137 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,413 Verified Shipments
731 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists